Medy Tox Correlations

086900 Stock  KRW 133,200  400.00  0.30%   
The current 90-days correlation between Medy Tox and Hugel Inc is 0.45 (i.e., Very weak diversification). The correlation of Medy Tox is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Medy Tox Correlation With Market

Significant diversification

The correlation between Medy Tox and DJI is 0.09 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Medy Tox and DJI in the same portfolio, assuming nothing else is changed.
  
The ability to find closely correlated positions to Medy Tox could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Medy Tox when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Medy Tox - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Medy Tox to buy it.

Moving together with Medy Stock

  0.72005935 Samsung ElectronicsPairCorr
  0.75005930 Samsung ElectronicsPairCorr
  0.8005490 POSCO HoldingsPairCorr
  0.66005387 Hyundai MotorPairCorr
  0.74005385 Hyundai MotorPairCorr
  0.82005380 Hyundai MotorPairCorr
  0.67000270 Kia CorpPairCorr

Moving against Medy Stock

  0.8035420 NaverPairCorr

Related Correlations Analysis

Please specify at least 3 valid symbols having historical data to build a meaningful correlation cloud. You can use symbol search above to locate your securities.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Medy Tox without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Insider Screener Now

   

Insider Screener

Find insiders across different sectors to evaluate their impact on performance
All  Next Launch Module

Medy Tox Corporate Management

Elected by the shareholders, the Medy Tox's board of directors comprises two types of representatives: Medy Tox inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Medy. The board's role is to monitor Medy Tox's management team and ensure that shareholders' interests are well served. Medy Tox's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Medy Tox's outside directors are responsible for providing unbiased perspectives on the board's policies.
HeeSeok JooManaging DivisionProfile
SeungBum ParkHead DirectorProfile
HyunHo JungCEO DirectorProfile
YongIn KimManaging DevelProfile
KiHyuk YangMD LaboratoryProfile
Lopez MichaelManaging OfficeProfile
WooSun LeeDirector DepartmentProfile